Shang-Gin Wu

Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations.

Yeun-Chung Chang, Jin-Yuan Shih, Yih-Leong Chang, 2011, Lung cancer.

Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern.

Meng-Feng Tsai, Chong-Jen Yu, Jin-Yuan Shih, 2008, The oncologist.